Nautilus Biotechnology, Inc.
NAUT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$13,574 | -$15,033 | -$16,613 | -$17,594 |
| Dep. & Amort. | $1,619 | $1,633 | $1,625 | $1,553 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $1,496 | $1,709 | $2,168 | $3,124 |
| Change in WC | -$269 | -$1,220 | -$576 | -$1,608 |
| Other Non-Cash | -$306 | -$439 | -$541 | $216 |
| Operating Cash Flow | -$11,034 | -$13,350 | -$13,937 | -$14,309 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$418 | -$396 | -$219 | -$254 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$27,493 | -$4,378 | -$6,900 | -$26,880 |
| Inv. Sales/Matur. | $28,363 | $19,248 | $26,630 | $65,000 |
| Other Inv. Act. | $0 | $0 | $0 | -$760 |
| Investing Cash Flow | $452 | $14,474 | $19,511 | $37,106 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $95 | $18 | $440 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $0 | $95 | $18 | $440 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$10,582 | $1,219 | $5,592 | $23,237 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $35,459 | $34,240 | $28,648 | $5,411 |
| End Cash | $24,877 | $35,459 | $34,240 | $28,648 |
| Free Cash Flow | -$11,452 | -$13,746 | -$14,156 | -$14,563 |